Using different cell type-specific knockout TSC mouse models, several groups showed that inhibiting mTORC1 using rapamycin has successfully rescued neuronal, oligodendroglial, astroglial, and microglial defects in the TSC rodent models [7, 85–87]. The gene discussed is TSC1; the disease is tuberous sclerosis.